Pharmacy Solutions

Press Releases

Onco360® Has Been Selected as a National Specialty Pharmacy Partner for Revuforj® (revumenib)

Onco360®, the nation’s leading independent Specialty Pharmacy, has been selected as a national pharmacy partner by Syndax Pharmaceuticals for Revuforj® (revumenib),…

Read More

Onco360® Has Been Selected as a National Specialty Pharmacy Partner for Itovebi™ (inavolisib)

Onco360®, the nation’s leading independent Specialty Pharmacy, has been selected as a pharmacy partner by Genentech, a member of the…

Read More

CareMed Has Been Selected as a National Specialty Pharmacy Partner for Lecanemab-irmb (Leqembi®)

CareMed, a leading independent Specialty Pharmacy, has been selected by Eisai to be in the pharmacy network for Leqembi® (lecanemab-irmb). Leqembi…

Read More

Onco360® Has Been Selected as The National Specialty Pharmacy Partner for Tevimbra® (tislelizumab-jsgr)

Onco360®, the nation’s leading independent Specialty Pharmacy, has been selected as a pharmacy partner by BeiGene for Tevimbra® (tislelizumab), approved…

Read More

LAZCLUZE™ (lazertinib) Now Available from Onco360 for the First-line Treatment, in Combination with Rybrevant®, of Adult Patients with Metastatic Non-Small Cell Lung Cancer Whose Tumors Have EGFR Exon 19 Deletions or Exon 21 L858R Mutations

Onco360®, the nation’s leading independent specialty pharmacy, has been selected as a pharmacy partner by Johnson & Johnson for LAZCLUZE™ (lazertinib)….

Read More

Onco360® Has Been Selected as a National Specialty Pharmacy Partner for VORANIGO® (vorasidenib)

Onco360®, the nation’s leading independent Specialty Pharmacy, has been selected by Servier Pharmaceuticals, as a specialty pharmacy partner for VORANIGO®…

Read More

Onco360® Has Been Selected as a National Specialty Pharmacy for crovalimab-akkz

Onco360®, the nation’s leading independent Specialty Pharmacy, has been selected by Genentech, a member of the Roche Group, to be…

Read More

Onco360 Selected as a Limited Distribution Specialty Pharmacy Partner for Rytelo™ (imetelstat)

Onco360®, the nation’s leading independent Specialty Pharmacy, has been selected as a pharmacy partner by Geron Corporation for Rytelo™ (imetelstat)…

Read More

NADONA/LTC Announces the 2024 Stephanie Carroll Memorial Scholarship Recipients Sponsored by PharMerica

The National Association Directors of Nursing Administration in Long-Term Care (NADONA/LTC) announces the winners of its Stephanie Carroll Memorial scholarships….

Read More

Ōmcare and PharMerica Team Up to Provide the Comprehensive Last Mile Solution to Tackle Medication Non-Adherence

Ōmcare today announced that it is collaborating with PharMerica to deliver a comprehensive last mile solution to address medication non-adherence,…

Read More

OJEMDA™ (tovorafenib) Now Available from Onco360 for the Treatment of Patients Six Months of Age and Older with Relapsed or Refractory Pediatric Low-Grade Glioma (LGG) Harboring a BRAF Fusion or Rearrangement, or BRAF V600 Mutation

Onco360®, the nation’s leading independent Specialty Pharmacy, has been selected as a pharmacy partner by Day One Biopharmaceuticals for OJEMDA™…

Read More

PharMerica Donates 719,287 Prescriptions to Underserved Patients in 2023

Fifty million Americans don’t take their prescribed medication because they can’t afford it, often making the impossible choice between medications…

Read More

Onco360 Has Been Selected as the Sole National Specialty Pharmacy Partner for Voydeya® (danicopan)

Onco360®, the nation’s leading independent Specialty Pharmacy, has been selected as a national pharmacy partner by Alexion Pharmaceuticals for Voydeya®…

Read More

Onco360 Selected as the Preferred National Specialty Pharmacy Partner for XPOVIO® (selinexor)

Onco360®, the nation’s largest independent Oncology Pharmacy, is now the national specialty pharmacy network partner for Karyopharm’s product XPOVIO ®…

Read More

PharMerica and NADONA Open Applications for 2024 Annual Stephanie Carroll Memorial Scholarship

PharMerica and the National Association of Directors of Nursing Administration in Long-Term Care (NADONA/LTC) have opened the application portal for…

Read More

Fabhalta (iptacopan) Now Available from Onco360 as the First FDA-Approved Oral Monotherapy Approved for the Treatment of Adults With Paroxysmal Nocturnal Hemoglobinuria (PNH)

Onco360®, the nation’s leading independent Specialty Pharmacy, has been selected as a pharmacy partner by Novartis for Fabhalta® (iptacopan) as…

Read More

PharMerica and Independent Living Systems Partner for New Pharmacy to Provide Comprehensive Care, Home Delivery to Miami Area Seniors

Independent Living Systems recently held a ribbon cutting for the first ILS Pharmacy, a new pharmacy solution that provides comprehensive…

Read More

TRUQAP™ (capivasertib) Now Available from Onco360

For the Treatment of Adult Patient with Hormone Receptor (HR)-positive, Human Epidermal Growth Factor Receptor 2 (HER2)-Negative, Locally Advanced or…

Read More

FRUZAQLA™ (fruquintinib) Now Available from Onco360 for the Treatment of Adult Patients with Metastatic Colorectal Cancer (mCRC)

Onco360®, the nation’s leading independent Specialty Pharmacy, has been selected as a pharmacy partner by Takeda for Fruzaqla™ (fruquintinib). Fruzaqla™,…

Read More

PharMerica Selects SinguLab to Deliver Pharmacogenomics Solutions for Facilities

SinguLab®, a nationwide provider of precision medicine and diagnostics solutions, today announced a strategic partnership with PharMerica, a large-scale pharmacy…

Read More

Axxess and OnePoint Patient Care Announce Product Integration for Pharmacy Benefit Management Services

Axxess and OnePoint Patient Care announced the integration of Axxess Hospice and OnePoint Patient Care’s Pharmacy Benefit Management platform. This…

Read More

Advanced Home Infusion Rebrands to Amerita

In 2020, Advanced Home Infusion became a part of Amerita. Since then, we’ve been working to gradually incorporate the Advanced…

Read More

PharMerica, NADONA Stephanie Carroll Memorial Scholarship Recipients Announced

The National Association Directors of Nursing Administration in Long-Term Care (NADONA/LTC) announced the winners of its Stephanie Carroll Memorial scholarships. The…

Read More

PharMerica Donates 820,739 Prescriptions to Underserved Patients in 2022

Partnership Helps Patients in Need Access Necessary Medications to Stay Healthy Nearly 1 in 4 Americans have difficulty affording their…

Read More

PharMerica, NADONA Open Applications for Annual Stephanie Carroll Memorial Scholarship

PharMerica and the National Association of Directors of Nursing Administration in Long-Term Care (NADONA/LTC) have opened the application portal for…

Read More

PharMerica Selected by New York OGS to Provide Pharmacy Services Throughout all Regions in New York State

PharMerica announced today that it has been awarded a contract, number PC69488, by the New York Office of General Services…

Read More

PharMerica Launches Continue Care Transitional Care Management Program

Today, PharMerica launched its Continue Care program to address gaps in care during residents’ transitions from skilled nursing facilities to…

Read More

PharMerica’s President Bob Dries Retires

It is with much gratitude that we announce the retirement of Bob Dries, President of PharMerica, for all of the…

Read More

PharMerica and Sharps Compliance Partner to Bring MedSafe to Long-Term Care Facilities

PharMerica, a nationwide leader in long-term care (LTC) pharmacy services, is partnering with Sharps Compliance Corp, a nationwide provider of…

Read More

PharMerica Team Members Go Above and Beyond During Power Outage

Recently, a PharMerica pharmacy in Warren, Michigan, lost power during a storm, and restoration wasn’t expected until later that evening.

Read More